Association between FAS polymorphism and prostate cancer development (Q58835504)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17667965%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

title

Association between FAS polymorphism and prostate cancer development (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17667965%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17667965%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17667965%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Morais A

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17667965%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Lobo F

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17667965%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Calais-da-Silva FM

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17667965%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Calais-da-Silva FE

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17667965%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

publication date

31 July 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17667965%20AND%20SRC:MED&resulttype=core&format=json

Prostate Cancer and Prostatic Diseases

2 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17667965%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17667965%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17667965%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

page(s)

94-98

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17667965%20AND%20SRC:MED&resulttype=core&format=json

Proliferation, cell cycle and apoptosis in cancer

2 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501002

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501002

The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501002

Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501002

Monoclonal antibody-mediated tumor regression by induction of apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501002

The Fas signalling pathway and its role in the pathogenesis of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501002

Defining CD95 as a tumor suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501002

Fas A670G polymorphism, apoptotic capacity in lymphocyte cultures, and risk of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501002

Functional polymorphisms in FAS and FASL contribute to increased apoptosis of tumor infiltration lymphocytes and risk of breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501002

Functional polymorphisms in cell death pathway genes FAS and FASL contribute to risk of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501002

Polymorphisms of FAS and FAS ligand genes involved in the death pathway and risk and progression of squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501002

Genetic polymorphisms of FAS and FASL (CD95/CD95L) genes in cervical carcinogenesis: An analysis of haplotype and gene-gene interaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501002

Molecular changes in prostatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501002

Leptin and prostate: implications for cancer prevention--overview of genetics and molecular interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501002

The link between obesity and prostate cancer: the leptin pathway and therapeutic perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501002

Acetylation genotype and the genetic susceptibility to prostate cancer in a southern European population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501002

Association between CYP2E1 polymorphisms and susceptibility to prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501002

Common genetic polymorphisms and prognosis of sporadic cancers: prostate cancer as a model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501002

Linkage between polymorphisms in the prostate specific antigen ARE1 gene region, prostate cancer risk, and circulating tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501002

Endothelial nitric oxide synthase gene polymorphisms and genetic susceptibility to prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501002

The role of vitamin D receptor gene polymorphisms in the susceptibility to prostate cancer of a southern European population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501002

Metabolic susceptibility genes and prostate cancer risk in a southern European population: the role of glutathione S-transferases GSTM1, GSTM3, and GSTT1 genetic polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501002

Overexpressing leptin genetic polymorphism (-2548 G/A) is associated with susceptibility to prostate cancer and risk of advanced disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501002

Linkage of angiotensin I-converting enzyme gene insertion/deletion polymorphism to the progression of human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501002

Steroid hormone genotypes ARStuI and ER325 are linked to the progression of human prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501002

Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501002

Prognostic significance of soluble Fas in the serum of patients with bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501002

Prognostic significance of a combination of soluble Fas and soluble Fas ligand in the serum of patients with Ta bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501002

Soluble Fas--a promising novel urinary marker for the detection of recurrent superficial bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501002

Polymorphism of Fas and Fas ligand in preterm premature rupture of membranes in singleton pregnancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501002

Fas gene promoter polymorphisms in primary Sjögren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501002

A polymorphism in FAS gene promoter associated with increased risk of nasopharyngeal carcinoma and correlated with anti-nuclear autoantibodies induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501002

7 January 2021

Re: Polymorphisms of death pathway genes FAS and FASL in esophageal squamous-cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501002

7 January 2021

Single nucleotide polymorphism at Fas promoter is associated with cervical carcinogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501002

7 January 2021

Polymorphisms of the FAS and FAS ligand genes associated with risk of cutaneous malignant melanoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501002

7 January 2021

Functional polymorphisms in the promoter regions of the FAS and FAS ligand genes and risk of bladder cancer in south China: a case-control analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501002

7 January 2021

Polymorphisms of death pathway genes FAS and FASL in esophageal squamous-cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501002

7 January 2021

Identification and characterisation of polymorphisms in the promoter region of the human Apo-1/Fas (CD95) gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501002

7 January 2021

International trends and patterns of prostate cancer incidence and mortality

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501002

7 January 2021

In vivo expression of soluble Fas and FAP-1: possible mechanisms of Fas resistance in human hepatoblastomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501002

7 January 2021

Fas and Fas ligand expression is elevated in prostatic intraepithelial neoplasia and prostatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501002

7 January 2021

Prognostic Significance of Serum Soluble Fas Level and Its Change during Regression and Progression of Advanced Prostate Cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501002

7 January 2021

Circulating soluble Fas in patients with breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501002

7 January 2021

Soluble Fas antigen in the serum of patients with colon cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501002

7 January 2021

CD95 polymorphisms are associated with susceptibility to MS in women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501002

7 January 2021

Genetic polymorphisms of Fas (CD95) and FasL (CD178) in human longevity: studies on centenarians

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501002

7 January 2021